Histopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial

Y. Emi, T. Yamanaka, K. Muro, H. Uetake, E. Oki, T. Takahashi, Y. Katayose, K. Yoshida, M. Sakamoto, S. Aishima, K. Ishida, J. Imura, M. Unno, I. Hyodo, N. Tomita, K. Sugihara, Y. Maehara

研究成果: Article査読

本文言語English
ページ(範囲)viii164
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータスPublished - 2018 10 1

ASJC Scopus subject areas

  • 血液学
  • 腫瘍学

引用スタイル